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Abstract
Dixon, David Allen. M.S., Microbiology and Immunology Graduate Program, Wright
State University, 2014. Development of a Co-culture System to Mimic the Transfection
of HSV-1 from Keratinocytes to Neuronal Cells

To more closely mimic the in vivo progression of HSV-1 a novel in vitro method was
created. In this study HEL-30 keratinocytes were infected with a 0.1 MOI of HSV-1 and
plated unto a membrane with 8μm diameter pores. The membrane insert was then placed
into culture wells that contained Neuro-2a cells (N2A). The neurites from the neuronal
cells made cell-to-cell contact with the infected HEL-30 cells and the virus was
transmitted into the neuronal cells. To determine if infection occurred in the N2A cells
the cells were lysed and the lysate incubated with Vero cells to titrate virus plaque
forming units. After incubation a virus plaque assay was performed and the results
compared with those of uninfected control cells. Methylcellulose was used to protect
against the HEL-30 cells lysing and releasing free virus particles into the medium and
infecting the N2A cells without cell-to-cell contact. The methylcellulose is viscous
enough to stop free virus particles from passage through the pore membrane in the
chamber infecting the N2A cells. Therefore, the only way that the N2A cells were
infected was if the neurites made direct contact with the infected keratinocytes, which
would mimic the “real world” progression of the virus from primary site of infection to
neuronal tissue infection. The use of methylcellulose in the co-culture system exerted a
profound inhibitory effect on free-floating virus particles. Immunofluorescence
iii

microscopy was used to confirm cell-to-cell contact between the N2A and HEL-30 cells
and to determine morphological differences that occur when the co-culture system is used
versus monoculture. This model provides a new system for studying host/virus
interactions.
The hypothesis of this study was that a method could be created that mimics the invivo transfection of HSV-1 from keratinocytes to neuronal cells using a co-culture
system. The neuronal cells would extend the neurite processes and make a connection to
the keratinocyte. Then the virus would be transferred into the neuronal cell without
diffusing freely into the media environment.
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INTRODUCTION
An in-vitro system mimicking the in-vivo transfection of HSV-1 between
keratinocytes and neuronal cells has not yet been well established. A model is needed that
keeps the cell populations separate, but allows cell-to-cell contact so the virus can move
directly from the keratinocytes to the neuronal cells. This would mimic the “real world”
progression of the virus in natural infection. The virus first enters epithelial cells via a
break in the skin or through the mucosal membrane, such as the mouth or eye. The virus
is then transported via retrograde flow along the axons into the nuclei of neuronal cells
where it remains latent (Whitley and Roizman 2001). Cell-to-cell contact is a crucial step
for this process to occur (Fig. 1, Fig. 2). In this study, a co-culture system was developed
to permit the transmission of HSV-1 from infected keratinocytes directly to neuronal
cells. This system involved the passage of virus to neuronal cell neurites protruding
through the 8μm pores of a membrane.
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Literature Review
Herpes Simplex Virus 1 and Infection
Herpes simplex virus 1 (HSV-1) is a member of the herpesviridae family. HSV-1
is associated with encephalitis and facial manifestations, such as scaring of the cornea
and blindness as well as sores on the lip. In order for initial infection to take place HSV-1
must contact mucosal surfaces or abraded skin to initiate infection. The incubation period
for HSV-1 ranges from 2-12 days with an average of 4. The viron is made up of four
parts: the electrodense core, which contains the large, double-stranded DNA molecule, a
capsid, a layer of proteins that surround the capsid, and the envelope (Roizman et al.
2007; Whitley and Roizman 2001). After infection and the incorporation of the viral
genome, the genome transcribes infected cell proteins 0, 4, and 22. These proteins alter
the environment inside the cell to allow efficient expression of the viral genes (Roizman
et al. 2007).
HSV-1 also has the ability to evade host immune responses. One way in which
the virus does this is by encoding a special protein that binds to the transporter proteins
transporter associated with antigen processing 1 and 2 (TAP 1 and TAP 2). This binding
inhibits the ability of the transporter protein to bind to other viral particles and
transporting then into the endoplasmic reticulum. This sequence of events blocks the
normal presentation by major histocompatibility protein (MHC)-class 1 to the host
immune system (Ward and Roizman 1994). Another host immune response is apoptosis
in response to disturbance of cellular machinery by viral proteins. HSV-1 has the ability
to block apoptosis. Although it is not fully understood, at least three proteins (US3, gJ,
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and gD) are thought to block apoptosis (Ward and Roizman 1994). Finally, HSV-1 can
inhibit the function of eukaryotic infection factor 2 α (eIF-2α). In uninfected cells this
protein is activated by phosphorylation and once activated it can block all protein
synthesis. HSV-1 is able to stop this process by transcribing the HSV-1 protein γ134·5.
This protein binds protein phosphatase 1 and directs it to dephosphorylate eIF-2α. This
dephosphorylation inactivates the protein thereby allowing the viral genome to be
transcribed. Also, cells cannot respond to infection because HSV-1 destroys cellular
messenger RNA (mRNA), inhibits DNA transcription, and blocks splicing of mRNA
(Ward and Roizman 1994; Whitley and Roizman 2001).
Since HSV-1 becomes latent in and resides in the central nervous system many
other manifestations of the disease can result. Viral infection can cause meningitis,
myelitis, and radiculitis, among other diseases. HSV-1 has also been isolated from the
respiratory tract of adults with adult respiratory distress syndrome and acute onset
bronchospasm. Lastly, HSV encephalitis is thought to be the most common cause of
sporadic fatal encephalitis (Whitley and Roizman 2001).
HSV-1 infection can be further divided into the initial infection of keratinocytes
and latency in the neuronal cells. The mechanism by which the virus enters the cell also
depends on the cell type (Nicola et al. 2005).
Keratinocytes and Infection
HSV-1 first infects keratinocytes in the mucous membranes. The virus must first
attach and fuse with the plasma membrane of the keratinocytes and this happens in
sequential steps. The first step is the binding of the viral glycoproteins gC and gB to
3

heparan sulfate molecules on the surface of the keratinocyte (Herold et al.1991; Johnson
et al. 1990). The viral particle then fuses with the cellular membrane using the viral
glycoprotein gD and the cellular receptor (Johnson et al.1990; Ligas and Johnson 1988).
It enters the cell through a variety of mechanisms. Nicola et al. have shown that the virus
uses a pH-dependent, endocytic pathway to enter the keratinocytes. Endocytosis, which is
sensitive to genistein and wortmannin may be required to bypass the dense layer of actin
under either the apical or basolateral plasma membrane of epithelial cells (Nicola et al.
2005).
The basal layer of the epidermis is richly innervated with unmyelinated sensory
neurites that form free terminals within the epidermis (Rice et al. 1998; Hilliges et al.
1995; Ulmann et al. 2007). Here the neurites make cell-to-cell contact with the
keratinocytes and the virus transfection to the neuronal cells takes place.
Neuronal Cells and Infection
After the primary infection of the keratinocytes, the virus migrates through the
axon terminal, which innervates the superficial dermis, into the sensory neuronal cells of
the trigeminal ganglia where it efficiently infects them and causes a lifelong infection. In
contrast to how the virus first enters keratinocytes, HSV-1 enters the neuronal cells via a
pH-independent pathway that is not affected by kinase inhibitors (Nicola et al. 2005).
Viral multiplication occurs only in a small percentage of neuronal cells and the viral
genome remains latent for the life of the host (Whitley and Roizman 2001). In the
neuronal cells the lytic genes of the virus can be turned off and the latent genes can
become transcribed (Goins et al. 1999; Stevens 1989). Once latent, the viral genome stays
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in the nucleus as an episome coiled around the nucleosomes (Deshmane and Fraser 1989,
Efstathiou et al. 1986; Mellerick and Frase 1987; Rock and Fraser 1985). The promoter
of the viral genome stays active during latency and causes latency-associated transcripts
(LATs) to become transcribed (Coen et al. 1987; Spivack and Fraser 1987; Stevens et al.
1987). These transcripts cause the lytic viral genome to remain latent. The lytic viral
genome can also be re-activated due to stressors such as physical or emotional stress, UV
light, fever, or tissue damage (Whitley and Roizman 2001). Once re-activated the virus
can produce the previously described symptoms. The virus is transported back to the
mucosal keratinocytes via the neurites resulting in recurrent infection.
Co-culture Stimulation via Nerve Growth Factor (NGF)
Upon stimulation, the keratinocyte HEL-30 cell line secrete a wide variety of
cytokines. One of these cytokines is nerve growth factor (NGF) (Feliciani et al. 1996).
NGF is a neurotropic factor that promotes the proliferation and differentiation of neurons.
It also enhances the ability of neuronal cells to produce neurites. Neuronal cells that have
been exposed to NGF can also withstand various treatments that would normally cause
the cell to go through apoptosis and even provide protection against signs of Alzheimer’s
disease (Goins et al. 1999; Hefti et al. 1989; Hefti et al. 1986; Korsching et al. 1986;
Levi-Montalcini et al. 1975; Levi-Montalcini et al. 1968; Thoenen and Barde 1980).
The in vivo administration of NGF is not very effective. The cytokine’s
effectiveness is limited by its short half-life and adverse side effects when delivered
systemically (Butcher and Wolfe 1989; Scott and Crutcher 1994; Taglialatela et al. 1997).
Since stimulated keratinocytes release NGF and therefore can cause neuronal cell
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protection, proliferation, and differentiation without the adverse side-effects associated
with systemic delivery, an HSV-1 vector might promote NGF release and protect
neuronal cells from various diseases and treatments. This idea has been explored, and
shown to work, by inserting an NGF transgene into the genome of HSV-1 while deleting
the cytotoxic genes (Goins et al. 1999).
Growth Cone of Neuronal Cells
Neuronal cells produce growth cones and filopodia to direct the outgrowth of
neurites in order to seek cellular connections and nutrients. The filopodia detect the
surrounding environment and act as sensory extensions of the neurite (Rehder and Kater
1992) (Fig. 3). Filopodia and growth cones are important for this study because after
HEL-30 cells become infected they release NGF. The filopodia detect the NGF and direct
the growth cone, and by extension the neurite, of the neuronal to the source of the NGF,
which is the HEL-30 cell. The growth cone will grow toward the higher concentrations of
NGF, which will direct the neurite to the HEL-30 cell, when it establishes a cell-to-cell
contact. This in turn will allow virus transfection to take place and the neuronal cell will
become infected with HSV-1.
Methylcellulose Properties
To better mimic the in vivo properties of a body, such as the basement membrane,
a physical barrier would need to be used that restricts the movement of free virus
particles. The substance that is used in this novel method is methylcellulose. Using
methylcellulose to conduct a plaque assay is one of the established methods for plaque
assays. Methylcellulose inhibits the spread of free-floating virus particles while
6

preserving cellular function (Stewart el al. 2001). Since the methylcellulose is made
containing the same medium that the cells are cultured in, the cells are able to proliferate
and differentiate as normal. The methylcellulose also does not affect adhesion properties
of the cells. The only way for virus to spread to other cells is if the plasma membrane of
the infected cell is touching the plasma membrane of a non-infected cell. Since the two
cell populations are kept separate in this experiment, the only way that the N2A cells can
become infected is for the N2A cell’s neurites to make contact with the infected HEL-30
cells.
Fetal Calf Serum
Like methylcellulose, fetal calf serum (FCS) is a crucial compound in the
proposed method. FCS contains a variety of growth promoting compounds that are
required for neuronal and keratinocyte cell growth. The main component of FCS that
allows for neuronal cell differentiation and proliferation is albumin (Zheng et al. 2006).
Also, a unique component of FCS that other common sera do not have, and which N2A
cells require is insulin growth factor-II (IGF-II). This potent mitogen includes the highest
number of unique peptides from all of the analyzed growth factors of FCS (Zheng et al.
2006). IGF-II also has binding proteins associated with it that affect cell growth. The
main binding proteins are insulin growth factor binding protein 2 and 4 (IGFBP2 and
IGFBP4). These proteins increase the half-life of IGF-II, which increases the
proliferation effects of IGF-II, and IGFBP2 stimulates cell spreading and proliferation
(Zheng et al. 2006).
Several other growth factors are found in FCS that are needed for cell growth. One
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of these factors is transforming growth factor beta (TGF-β). TGF-β is a crucial peptide
whose functions include proliferation and differentiation. It also regulates the action of
other growth factors by determining either a positive or negative effect of the growth
factors (Zheng et al. 2006; Nowak et al. 1999). FCS also contains is glial growth factor
(GGF). GGF is one of the isoforms of neuregulin 1 that induce the growth and
differentiation of epithelial and neuronal cells through interaction with transmembrane
receptors of tyrosine kinase (Zheng et al. 2006; Burden and Yarden 1997). These growth
factors are not all inclusive, but they are the main ones that neuronal cells and
keratinocytes need that separate FCS from other common cell culture sera (Zheng et al.
2006.
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Materials and Methods
Cell Lines
The Neuronal 2-a (N2A) (ATCC; CCL- 131) cell line was obtained from murine
neuroblastoma cells and is adherent. The average length of the cell ranges from 25µm
when the cells are first plated and dividing, to 100 µm when the cell is differentiating and
producing neurites (Letourneau et al. 1986). N2A cells were cultured in 60mm x 20mm
cell culture treated petri dishes (Corning) and incubated in a humidified atmosphere with
5% CO2 at 37° C. Cells were cultured and maintained with Dulbecco’s Modified Eagle’s
Medium (DMEM) (HyClone) supplemented with 10% or 5% fetal calf serum (FCS)
(Fisher brand) and 1% penicillin-streptomycin (10000U/mL Penicillin and 10000U/mL
Streptomycin). The HEL-30 cell line was derived from murine epidermal cells of C3H
mice. It was also cultured in 60mm x 20mm cell culture treated petri dishes and incubated
in a humidified atmosphere with 5% CO2 at 37° C. Cells were cultured and maintained
with Dulbecco’s Modified Eagle’s Medium (DMEM) (HyClone) supplemented with 10%
fetal calf serum (FCS) (Fisher brand) and 1% penicillin-streptomycin (10000U/mL
Penicillin and 10000U/mL Streptomycin). The Vero cell line (ATCC CCL-81) was
derived from the kidney cells of the grivet monkey and is used in this study for plaque
assays. It was also cultured in 60mm x 20mm cell culture treated petri dishes and
incubated in a humidified atmosphere with 5% CO2 at 37° C. Cells were cultured and
maintained with Dulbecco’s Modified Eagle’s Medium (DMEM) (HyClone)
supplemented with 10% or 5% fetal calf serum (FCS) (Fisher brand) and 1% penicillinstreptomycin (10000U/mL Penicillin and 10000U/mL Streptomycin). Cells were subcultured every two days at a split ratio of 1:6 throughout the course of this study. To
9

release the adherent cells from the plate the cells were first washed with 1X PBS and then
the plates were incubated with 1mL of a 0.25% Trypsin-EDTA solution (Gibco-Life
Technologies) for 5 minutes. The trypsin was then neutralized with 1 mL of medium and
the cells were spun down and re-plated.
Virus Culture and Quantification
Stock sample of Herpes Simplex Virus-1 strain Syn 17+ initially obtained through
Dr. Nancy Sawtell, Children’s Hospital Medical Center Cincinnati, OH. The virus was
propagated on 100% confluent monolayers of Vero cells. When cytopathic effect,
damage to the cells during viral invasion (plaques), became evident, around day 5 post
infection, the cells were spun down and the supernatant was aliquoted into 1mL micro
centrifuge tubes and stored at -80°C. A dilution of 0.1 multiplicity of infection (MOI)
was calculated by infecting Vero cell monolayers with different dilutions of virus and
counting the plaques. The dilution that resulted in a MOI of 0.1 was used for this study.
Cell Viability
After co-culturing for 4 days, leading to around 80% confluency, with or without
virus, the N2A cells were detached from the plate using trypsin. The cells were then
stained with Trypan Blue and placed upon a hemocytometer.
Immunofluorescent Staining
Representative fields were selected by choosing a field that had on average the
same number of cells in it for each image. N2A and HEL-30 cells were co-cultured to
approximately 70% confluency. The medium was then removed and the cells were

10

stained. A neurite outgrowth staining kit was used to prepare the stains (Molecular
Probes-Life Technologies). The 1X working stain solution was prepared by placing 10μL
of the cell viability indicator and cell membrane stain into 10mL of 1X phosphate
buffered saline (PBS). An application volume of 1.5mL of staining solution per well was
then used. The cells were then incubated for 20 minutes at 37°C. After 20 minutes, the
solution was aspirated and the cells were washed with 1X PBS. Then 1.5mL of a
background suppression dye was applied. The dye was diluted100-fold by adding 100μL
of the dye to 10mL of 1X PBS. Once the dye was applied, the cells were visualized on an
inverted fluorescent microscope. In order to detect the cell viability stain, an excitation of
495nm was used to produce a green fluorescence. The viability indicator dye is converted
by the intracellular esterase activity of living cells to emit green fluorescence primarily in
the neural cell bodies. To read the cell membrane stain a 555nm wavelength was used to
produce a red fluorescence. Since the thickness of the culture dish is thicker than the ideal
glass coverslip, this resulted in some degradation of the resulting images taken on the
inverted fluorescence microscope to not be at optimal sharpness. The company does not
reference the exact components of the cell viability and neurite outgrowth stains.
Plaque Assay
After infection, the inserts containing the HEL-30 cells were removed and
discarded. The medium left in the culture plates was aspirated. The N2A cells were then
washed in 1x PBS and removed following the method previously described. After the
cells were spun down at 1500rpm for 5 minutes the supernatant was aspirated and the cell
pellet was re-suspended. The cell-containing solution was then placed into a -80°C. The
cells were put through a freeze-thaw cycle 4 times in order to lyse the cells and free the
11

virus. After the fourth cycle, the cells were spun down. The resulting supernatant was
then used to infect Vero cells grown to 100% confluency for 2 hours. After 2 hours of
absorption, the medium was aspirated and 2 ml of Opti-MEM GlutaMAX (Life
Technologies Inc.) containing 2% Methylcellulose (Acros Organics) and 0.5% fetal
bovine serum was laid over the Vero cells. The cultures were incubated at 37 °C until
plaques began to form, usually around day 5 or 6, and then counted for plaque formation
after ﬁxation with 4% paraformaldehyde and staining with 1% crystal violet solution
(Sigma).
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Results
Percent Serum Affects Neurite Growth
In determining the best concentration of FCS to use in culture medium to culture
the N2A cells, the standard 10% concentration that other studies have used and a 5%
concentration were used. When the N2A cells were cultured alone in the 10% FCS
medium they produced small, multidirectional neurite processes. When the cells were
grown in a medium containing 5% FCS the cells produced larger and fewer neurites with
an average length of 75-100 µm (Fig. 4). The ends of the neurites also showed signs of
growth cones. The cells grown in the 5% FCS media also produced growth cones. In vivo
the cells produce growth cones. So, these cells more closely resemble cells in the human
body versus cells grown in the 10% FCS media. Both serum concentrations resulted in
N2A cell growth and differentiation although the cells grown in the 10% concentration
came to 70% confluency 1-2 days faster than the cells grown in the 5% concentration.
Since the neuronal cells grown in the 5 % FCS medium grew longer neurites than the
cells grown in the 10% FCS media, in the co-culture experiments the cells were only
grown in the 5% FCS media.
Protocol Set-up
The purpose of the study was to be able to keep the two cell populations separate
so that each population could be studied and imaged individually. This is why a porous
membrane that fits into the culture dish was used (Fig. 5). With the pore diameter being
8µm and the average width of a neurite being 1.1µm there is adequate space for the
neurite to grow through the pore without being impeded (Letourneau et al. 1986). N2A
13

cells were first seeded onto the bottom of a 6-well culture plate and grown to a
confluency of 20% in medium containing either 5 or 10% FCS. After the HEL-30 cells
came to the desired level of confluency they were plated on top of the porous membrane
insert and placed into each well. This membrane kept the two populations separate, while
the pores allowed the N2A neurites to make cell-to-cell contact with the HEL-30 cells.
To determine if the two cell populations made cell-to-cell contact and allow the
transfection of virus, after the medium had been aspirated a layer of methylcellulose was
placed on top of the N2A cells at 40% confluency. The membrane was placed on top of
the methylcellulose-coated N2A cells. The HEL-30 cells, which were previously infected
with a 0.1 MOI of HSV-1 in a different dish, were then plated on top of the membrane
along with 10% FCS medium. Thus, the methylcellulose and the porous membrane
separated the two cell populations. Methylcellulose was used to block diffusion of free
virus particles to the neuronal cells. The only way that the virus could infect the neuronal
cells is for the virus to exit the keratinocytes through exocytosis and then taken into the
neuronal cells through endocytosis. The pores would also allow cytokines produced by
the two cell populations to flow back and forth throughout the medium.
Co-culture Morphological Changes
When the N2A cells were co-cultured with the 0.1 MOI HSV-1 infected HEL-30
cells, the neuronal cells underwent morphological changes (Fig. 6). The neuronal cells
produced fewer and longer neurites. The neuronal cells produce nodules on their neurites.
These nodules are presumably neurite processes coming from the main neurite and
protruding through the pores in the membrane above.
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Upon co-culture with 0.1 MOI HSV-1 infected HEL-30, the morphology of the
N2A cells changes when compared to control N2A cells. The N2A cells co-cultured with
the infected HEL-30 cells become rounded and the neurites become rounded as well. The
N2A cells also produce more neurites than the control cells (Fig. 7). The N2A cells cocultured with the infected HEL-30 cells differentiated at a faster rate as well and reach
70% confluency 2 days before the control cells did.
Plaque Assay
To determine if this co-culture protocol allowed for the transfection of HSV-1
from infected keratinocytes to neuronal cells without the diffusion of free virus particles
into the media various plaque assays were performed. N2A cells grown in 5% FCS
medium alone were used as a negative control, N2A cells grown in 5% FCS medium
infected with 0.1 MOI HSV-1 were used as a negative control. Then the N2A cells were
co-cultured with the HEL-30 cells as previously described. The HEL-30 cells were
infected with 0.1 MOI of virus. Two set-ups were used to determine the efficacy of the
protocol with methylcellulose. In the first set-up the medium that the N2A cells were
growing in was replaced with methylcellulose once the porous insert containing the
infected HEL-30 cells was placed into the culture dish. In the other group only medium
was used and not methylcellulose. When the plaque assay was conducted using the lysate
from the group in which methylcellulose was used and compared to the group in which
no methylcellulose was used, the N2A cells that were grown with methylcellulose had
fewer plaques comparable to the initial infection of 0.1 MOI (Fig. 8). The group that was
cultured with methylcellulose contained plaques equivalent to the initial infection rate of
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0.1 MOI, while the group that was not cultured with methylcellulose had plaques too
numerous to count.
Immunofluorescence
Immunofluorescence imaging was used to show cell-to-cell contact points and
cell viability (Fig. 9). All cell populations were plated at the same density and a striking
difference can be seen between the N2A cells grown alone or co-cultured with HEL-30
cells (Fig. 10). Co-culturing causes the cells to differentiate at a faster rate and produce
more neurites (Fig. 9,10). Immunofluorescence microscopy also revealed neurites of the
N2A cells growing up through the pores and making cell-to-cell contact with the HEL-30
cells when imaged from the HEL-30 level of the membrane (Fig. 11).
Images from the same area of the culture dish, at the N2A level and then the
HEL-30 level (membrane level), were also taken to permit overlaying (Fig. 12). The
overlay demonstrates how the neurites growing through the pores block the
differentiation of HEL-30 cells in the area that is occupied by the neurites. The neurites
then make cell-to-cell contact with the HEL-30 cells and virus transfection can take place
along the neurites. The image reveals small dot-like objects, which appear to be neurites
sticking up through the pores in close proximity and sometimes next to the cell
membrane of the HEL-30 cells.
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Discussion
In this study a novel in vitro protocol to mimic the in vivo transfection of HSV-1
from keratinocytes to neuronal cells was established. First, N2A cells were cultured to
20% confluency. The old medium was aspirated and the cells were washed with PBS.
Methylcellulose was then placed into the culture dishes on top of the N2A cells. A porous
membrane with 8μm diameter pores was then placed into the culture dishes. HEL-30
cells were infected at a 0.1 MOI of HSV-1 and plated onto each membrane insert with
10% FCS medium. The culture plate was then incubated for 48 hours at 5% CO2. After
48 hours, the insert and methylcellulose were removed and the N2A cells were taken off
of the plate. The resulting pellet was re-suspended in 10% FCS medium and placed into a
freezer. The cells were lysed using freeze-thaw cycles. After three cycles, the cells were
pelleted again and the lysate used to infect Vero cells for plaque assays.
Throughout the course of this study, the percentage of FCS in the medium
affected neurite outgrowth and N2A cell differentiation. A possible explanation of this
phenomenon was studied by Zheng et al. 2005, whose work using embryonic stem cells
showed that lowering the concentration of FCS in stem cells leads to arrest of the cells in
the G0/G1 phase. Increasing the concentration leads to normal cell differentiation
throughout all phases of the cell cycle (Zheng et al. 2005). Since the current study used a
lower concentration of FCS (5%), the cells were not completely starved of serum, but the
lower FCS concentration may have slowed cell differentiation and proliferation. This
slower growth might be the reason why we saw the N2A cells grown in the 5% FCS
medium produce fewer, yet longer neurite processes. Since the cells were in the G0/G1
phase longer, they could produce longer neurites rather than going through the cell phases
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at the normal rate. Future studies could explore on how to arrest the cell cycle of the N2A
cells once the neurites are at a desired length without causing the cells to go through
apoptosis. This could be applied by creating a more controllable co-culture protocol by
arresting the cell cycle and using only one cell-to-cell contact point between the neuronal
cells and keratinocytes.
This proposed novel method for studying the transfection of keratinocytes and
neuronal cells with HSV-1 is a suitable in vitro model that can be applied to the in vivo
cycle of HSV-1. It has already been shown that the progression of HSV-1 infection in
vivo is that first the virus infects the keratinocytes and then proceeds to infect neuronal
cells by being taken into the cell through the neurites (Rice et al. 1998; Hilliges et al.
1995; Ulmann et al. 2007). The virus becomes latent in the neuronal cells and can then be
reactivated to travel back through the neurites to re-infect the keratinocytes, leading to
symptoms. The proposed in vitro method in this paper mimics the in vivo progression of
the virus; the keratinocytes are first infected with HSV-1 and plated in a co-culture
system so in order for the neuronal cells to become infected a cell-to-cell contact must
take place by the neurites making contact with the infected keratinocytes. It is only then
that the virus can infect the neuronal cells.
Because I did not have access to a confocal fluorescent microscope, this
experimental procedure should be repeated using a fluorescent confocal microscope. It
would produce images where you could follow the neurite growth through the pores and
making contact with the HEL-30 cells. This current research paper was only able to take
images at two levels and then artificially overlay them to try and show the growth of the
neurite. Confocal images would more clearly show the growth of the neurite through the
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pores and cell-to-cell contact. The purpose of this experiment would be to better show the
contact points between the neurites and the keratinocytes.
A future study could look at NGF more in-depth using multiple methods, since
infected keratinocytes produce NGF, which acts as a chemotactic and causes neuronal
cells to differentiate. First, the method outlined by this thesis could be used as a set up
and then NGF could be blocked by using a blocking antibody. Then one could see if the
N2A cells would still differentiate at the same rate and if the neurites would still make
contact with the infected HEL-30 cells. Instead of using infected HEL-30 cells, one could
place pure NGF at a concentration similar to the concentration produced and released by
infected HEL-30 cells in the top chamber along with 5% FCS medium and see if the N2A
cells still produce neurites that protrude through the pores. The results obtained by using
an electron microscope to verify contact points and viral transfer could be used to
determine if the neurites only make cell-to-cell contact by coincidence, or if it truly is a
result of the infection causing the HEL-30 cells to release NGF and thereby causing
chemotaxis of the neurites to make contact the HEL-30 cell.
It has been shown that nectin-1 (synonymous with herpes virus entry protein C) is
a critical entry receptor found on neuronal cells to which HSV-1 attaches and gains entry
into the cell (Akhtar, Tiwari, Oh, et al. 2008). Future research could be done to further
prove the effectiveness of this novel co-culture method by focusing on the nectin-1
receptor on the neuronal cells. An experiment could be set up using the co-culture
method with the addition of a nectcin-1 antibody to block the binding of HSV-1 on
nectin-1. This should protect the neuronal cells from infection. Images could be taken to
show that the neurites are still making cell-to-cell contact with the infected HEL-30 cells;
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virus transfection should not take place since the antibody is blocking the nectin-1
receptor.
Another possible application of this protocol is to infect the neuronal cells and
keep the keratinocytes uninfected. The cells could be cultured in the same positions as
described in this study. This application could demonstrate the migration of HSV-1 back
to the keratinocytes upon reactivation. Then with these two protocols further
experimentation to protect either the neuronal cells or keratinocytes could be undertaken
by 1) making the virus stay latent in the neuronal cells by using treatments such as
acyclovir, or 2) protecting the neuronal cells from virus transfection. The in vivo
applications of these two experiments would be to create a better drug that keeps the
virus in latency in the neuronal cells so that it cannot become reactivated. One way to
keep the virus in latency and therefore keep the virus from reactivating in neuronal cells
is through the use of acyclovir (Sawtell et al. 2001).
Previous studies have only focused on using acyclovir on neuronal cells to keep
the virus latent (Smith et al. 2001; Margolis et al. 2007; and Roehm et al. 2011).
However, the effects of the drug on other cell populations such as keratinocytes have not
been studied. A novel study could use the protocol established in this thesis with infected
neuronal cells and acyclovir treatment. The researchers could then determine the different
cytokines produced by aspirating the cell culture media and analyzing it. They could then
see if the treatment has any effect on the non-infected keratinocytes, such as cytotoxicity
by comparing the cell viability of keratinocytes grown in the presence or absence of
acyclovir. Another in vivo application would be to develop a treatment that would
prevent the keratinocytes from becoming infected in the primary stage of infection such
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as a type of injection that contains a molecule that binds to and blocks the different
receptors that HSV-1 binds to.
This established protocol could be used for any future research that requires cellto-cell contact through processes, while keeping the two cell populations separate. It
could also be used to show how cytokines produced by one type of cell can influence the
differentiation and proliferation of another type of cell. Future research could focus on
the cytokines produced by the infected keratinocytes and how these cytokines affected
the neurite and cellular growth that has been seen in this study.
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Summary
The purpose of this study was to develop a novel co-culture protocol to culture
neuronal cells and HSV-1 infected keratinocytes while keeping the two populations
physically separate. This protocol mimics the in vivo progression of HSV-1 from the
primary infection of keratinocytes to transfection of the neuronal cells. The results of this
study suggest that this protocol permits studying the transfection of HSV-1 from
keratinocytes to neuronal cells. This protocol may also be helpful in studying virus
transfection between two other cell types. This protocol is simple to establish and to
make morphological observations, and the materials are easily obtainable. When using
the membrane inserts in the culture dish with methylcellulose covering the N2A cells, the
protocol allows the N2A neurites to make contact with the infected HEL-30 cells and
thereby allowing viral transfection into the N2A cells. The methylcellulose inhibits N2A
infection by free-floating virus particles that have been released from lysed HEL-30 cells.
Therefore, the only way that N2A cells can become infected with HSV-1 is through cellto-cell contact made by the N2A neurites attaching to the HEL-30 cells.
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Figures

Figure 1. Model of HSV-1 life cycle based upon Lachmann (2003) and redrawn to
better show HSV-1 lifecycle. Hexagons represent HSV-1 without the viral envelope
in the cell and circles represent HSV-1 with viral envelope when it is transported of
the cell via exocytosis before the next cell takes it up via endocytosis. This figure
depicts the primary infection of HSV-1 in epithelial/keratinocyte cells leading to
latency in neuronal cells. Subsequently, it shows the pathway of HSV-1 upon
reactivation in neuronal cells to infection of the epithelial/keratinocyte.
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Figure 2 Transmission of HSV-1 along axons in neuronal cells. Image shows the
progression of HSV-1 to become latent in neuronal cells or the reactivation of the
virus and the migration into keratinocytes. Adapted from Szpara et al. (2010).
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Figure 3 Neuronal growth cone and filopodia. Image of the growth cone on a neuronal cell
and the filopodia extending from the growth cone. The filopodia detect the surrounding
environment for chemoattractants and nutrients and direct the growth of the growth cone
and neurite to the highest concentration of nutrients and chemoattractants. Adapted from
Rehder and Kater (1992).

25

A.

B.

Figure 4. Morphological differences in neuroblastoma cell neurites between using 5% or
10% serum. Image taken at objective magnification 40x. Cells seeded at same time and
image taken at day 4 post seeding. A) Using medium that contains 5% FCS causes longer
and unidirectional neurite outgrowth. Red circle outlines growth cone. B) Using medim
that contains 10% FCS results in smaller multidirectional neurite outgrowth. No growth
cones form in the cells grown in the 10% serum. Scale bars represent 20 µm.
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A.

B.

Figure 5. Co-Culture set-up. A) A schematic of how the membrane insert fits inside the
culture dish containing the N2A cells. B) Red circle outlines pore in the membrane. All
closed in circles are pores.
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Figure 6. Neurites protruding through the pore membrane. Image taken at day 4 after
seeding. Circle outlines a nodule that can be seen in the N2A cells co-cultured with
infected HEL-30 cells. The nodules result from the release of NGF by the infected HEL30 cells. NGF acts as a chemoattractant to the neurites.
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A.

B.

20 μm

Figure 7. Comparison of morphology of infected and non-infected cells. Morphological
changes of infected cells grown in 5% serum 48 hours post infection. A) Image taken at
day 4 post seeding of N2A cell grown in 5% FCS without the addition of infected HEL30 cells. B) Image taken of infected N2A cells. Infected cells become rounded with
shorter neurites. Difference in color of the background reflects the color of the media.
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A.

B.

Figure 8. HSV-1 plaque assay. Plaque assay of infected N2A cell lysate grown in 5%
serum using the previously described method with or without methylcellulose. A) Coculture method without the use of methylcellulose. Without methylcellulose in the system
free-floating virus particles was able to infect the neuronal cells. B) Co-Culture method
with the use of methylcellulose. The use of methylcellulose resulted in fewer virus
plaques, indicating a requirement for cell-to-cell contact for virus transfection between
the neuronal cells and keratinocytes.
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A.

B.

C.

D.

Figure 9. Immunofluorescence imaging of N2A cells in 5% serum. Image taken at day 4
after seeding. Imaging of N2A cells grown without co-culture of HEL-30 cells. A) Phase
contrast image. B) Neurite outgrowth stain. Only neuronal cells are able to take up the
stain into the neurites and fluoresce red. C) Viability stain. Only live cells are able to take
up the stain and thereby fluoresce green. D) Merge image of the viability stain and
neurite stain. The reason why all the cells stain green and therefore are viable is because
the cells are first washed before the stain in applied and the washing would remove any
dead cells since dead cells become non-adherent. Scale bar represents 20 μm.
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A.

B.

C.

D.

Figure 10. Imaging of N2A cells grown in 5% serum with the co-culture of HEL-30
cells. Image taken at day 4 after seeding at objective magnification 40x. A) Phase
contrast image. B) Neurite outgrowth stain. Only neuronal cells are able to take up the
stain into the neurites and fluoresce red. C) Viability stain. Only live cells are able to take
up the stain and thereby fluoresce green. D) Merge image of the viability stain and
neurite stain. Scale bar represents 20 μm.
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A.

B.

C.

D.

Figure 11. Imaging taken on day 4 after seeding of HEL-30 cells co-cultured with N2A
cells grown in 5% serum. Circles outline an image of a cell gorwing underneath the level
of the HEL-30 cells, which is that of an N2A cell and the neurites protruding upward
through the pores. A) Phase contrast image. B) Neurite outgrowth stain. Only neuronal
cells are able to take up the stain into the neurites and fluoresce red. C) Viability stain.
Only live cells are able to take up the stain and thereby fluoresce green. D) Merge image
of the viability stain and neurite stain. Scale bar represents 20 μm.
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A.

B.
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D.

E.
Figure 12. Overlay of images taken at day 4 after seeding. A side-by-side comparison
of images taken from the N2A level and HEL-30 level on day 4 grown in 5% FCS serum
without moving the microscope stage. Circle outlines a neurite in close proximity of an
HEL-30 cell. There are at least 20 neurites total in the field. A) Phase contrast image. B)
Neurite outgrowth stain. Only neuronal cells are able to take up the stain into the neurites
and fluoresce red. C) Viability stain. Only live cells are able to take up the stain and
thereby fluoresce green. D) Merge image of the viability stain and neurite stain. E) An
overlay of two images, one taken from the N2A level and one taken from the HEL-30
level. Red image is from N2A level and green image is from HEL-30 level. Scale bar
represents 20 μm.
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